Back
Xeris Biopharma Holdings Stock Price Chart
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!
Buy
86
XERS
Xeris Biopharma Holdings
Last Price:
$5.87
Seasonality Move:
52.1%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.28 | Buy |
| 20-day SMA: | 4.48 | Buy |
| 50-day SMA: | 3.9 | Buy |
| 200-day SMA: | 3.09 | Buy |
| 8-day EMA: | 5.32 | Buy |
| 20-day EMA: | 4.72 | Buy |
| 50-day EMA: | 4.13 | Buy |
| 200-day EMA: | 3.27 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 83.6 | Buy |
| Chaikin Money Flow: | 1520073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.62 - 5.06) | Buy |
| Bollinger Bands (100): | (3.03 - 4.19) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 5.87 while XERS 8-day simple moving average is 5.28, which is a Buy signal.
-
The stock price of XERS is 5.87 while Xeris Biopharma Holdings 20-day SMA is 4.48, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day simple moving average is 3.90 while XERS share price is 5.87, making it a Buy technically.
-
XERS stock price is 5.87 and Xeris Biopharma Holdings 200-day simple moving average is 3.09, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
86
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a BuyThe current Xeris Biopharma Holdings [XERS] share price is $5.87. The Score for XERS is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
903.6M
Price in USD:
5.87
Share Volume:
3.9M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
5.92
52-Week Low:
1.69
Buy
86
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?The Xeris Biopharma Holdings stock price is 5.87 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 5.87 while XERS 8-day exponential moving average is 5.32, which is a Buy signal.
-
The stock price of XERS is 5.87 while Xeris Biopharma Holdings 20-day EMA is 4.72, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day exponential moving average is 4.13 while XERS share price is 5.87, making it a Buy technically.
-
XERS stock price is 5.87 and Xeris Biopharma Holdings 200-day simple moving average is 3.27, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.15 per share, and an increase next year of $0.02 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting Xeris Biopharma Holdings is a Buy
-
Xeris Biopharma Holdings Relative Strength Index (RSI) is 83.6, which suggest Xeris Biopharma Holdings is overbought
-
The Bollinger Bands (25) for Xeris Biopharma Holdings is (3.62 - 5.06), which suggest Xeris Biopharma Holdings is a Buy
-
The Bollinger Bands (100) for Xeris Biopharma Holdings is (3.03 - 4.19), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.